FindTrial
Sign In

Role of metformin in COVID-19 patients with diabetes.

Metformin use and associated clinical outcomes in COVID-19 patients with diabetes.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/02/040064
Enrollment
210
Registered
2022-02-07
Start date
Unknown
Completion date
Unknown
Last updated
2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: E119- Type 2 diabetes mellitus without complications

Interventions

None listed

Sponsors

Manipal Academy Of Higher Education
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients on metformin, patients who are hospitalized with covid-19.

Exclusion criteria

Exclusion criteria: Patients with other chronic conditions

Design outcomes

Primary

MeasureTime frame
MortalityTimepoint: January 2022, December 2022—

Secondary

MeasureTime frame
Number of readmission In hospital mortality number of days hospitalised number of days on ventilation change in level of inflammatory markers Clinical improvementTimepoint: January 2022, December 2022—

Countries

India

Contacts

Public ContactSanjay Kurian Mathew

Department Of Pharmacy Practice, Manipal College Of Pharmaceutical Sciences.

sonal.sekhar@manipal.edu8825804811

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026